We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
ProImmune Launches B Cell ELISpot Assay Service
Product News

ProImmune Launches B Cell ELISpot Assay Service

ProImmune Launches B Cell ELISpot Assay Service
Product News

ProImmune Launches B Cell ELISpot Assay Service


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "ProImmune Launches B Cell ELISpot Assay Service"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

ProImmune Ltd. has launched the B cell ELISpot assay as a service. The B cell ELISpot assay is central to the characterization of adaptive immune responses to infection, immune modulators, vaccines and therapeutic agents.

Used to quantify the number of memory B cells that can be re-stimulated to produce antibody against a specific antigen, B cell ELISpot enables the activity of antibody-secreting memory B cells to be characterized at a cellular level.

This gives a more detailed reading of immune responses in contrast to an ELISA-type assay, which measures total levels of secreted antibodies in a sample.

Dr Nikolai Schwabe, CEO of ProImmune said: “The B cell ELISpot is a highly valuable assay offering a superior method for characterization of memory antibody responses, the investigation of which forms a mainstay of evaluating functional immune responses. Although the assay is technically challenging, requiring extensive experience, when performed correctly it is very robust and is therefore very well suited to be run as a core facility service.”

To read further information about the B Cell ELISpot Assay Service, please visit http://bit.ly/HPHW4R.

Advertisement